Tag: the-presence
-
Iraqi civilians stranded north of Mosul grow desperate
By Stephen Kalin BAYBUKH, Iraq (Reuters) – Hundreds of civilians who fled fighting near Islamic State-controlled Mosul last week are stranded without basic humanitarian assistance, underlining the challenges of the largest military operation in Iraq in over a decade. Families have been living for up to six days in abandoned homes and a school building…
-
Iraqi civilians stranded north of Mosul grow desperate
By Stephen Kalin BAYBUKH, Iraq (Reuters) – Hundreds of civilians who fled fighting near Islamic State-controlled Mosul last week are stranded without basic humanitarian assistance, underlining the challenges of the largest military operation in Iraq in over a decade. Families have been living for up to six days in abandoned homes and a school building…
-
Dynavax says FDA rejects its hepatitis B vaccine
(Reuters) – The U.S. Food and Drug Administration rejected Dynavax Technologies Corp's marketing application for its hepatitis B vaccine, Heplisav-B, for the second time in three years, sending the company's shares tumbling 71 percent in premarket trade. The drug developer said on Monday it received a “complete response letter” from the FDA, seeking information about…
-
Conatus liver drug shows promise in mid-stage trial
(Reuters) – Conatus Pharmaceuticals Inc said its experimental drug reduced the presence of a protein fragment in patients with liver cirrhosis in a mid-stage trial. The drug, emricasan, showed a statistically significant reduction in the protein fragment, caspase-cleaved cytokeratin 18 (cCK18), when compared with a placebo, in the overall patient population, according to the three-month…
-
Conatus liver drug shows promise in mid-stage trial
(Reuters) – Conatus Pharmaceuticals Inc said its experimental drug reduced the presence of a protein fragment in patients with liver cirrhosis in a mid-stage trial. The drug, emricasan, showed a statistically significant reduction in the protein fragment, caspase-cleaved cytokeratin 18 (cCK18), when compared with a placebo, in the overall patient population, according to the three-month…
-
Valeant plans to appoint new CEO as Pearson remains hospitalized: WSJ
(Reuters) – Valeant Pharmaceuticals International Inc is planning to appoint a new CEO as Chief Executive Michael Pearson remains hospitalized, the Wall Street Journal said, citing people familiar with the matter. The new chief executive would replace the committee currently running the company, the newspaper said. Potential new chief executive candidates include Chief Financial Officer…
-
Eli Lilly’s diabetes pill takes market share from J&J, Astra
Eli Lilly and Co’s new Jardiance diabetes treatment has begun stealing market share from rival drugs in its class, the company said on Tuesday, bolstered by clinical trial data showing it slashed deaths by 32 percent in patients with Type 2 diabetes. In a three-year study whose results were released last summer, Jardiance became the…